Aquestive Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Aquestive Therapeutics

05/11/2024 07:54

* Aquestive Therapeutics Inc  AQST.OQ  reported a quarterly
adjusted loss of 13 cents​​ per share for the quarter ended
September 30, lower than the same quarter last year, when the
company reported EPS of -3 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 13 cents per
share. Wall Street expected results to range from -14 cents
to -9 cents per share.
    * Revenue rose 18.7% to $13.54 million from a year ago;
analysts
expected $12.68 million. 
    * Aquestive Therapeutics Inc's reported EPS for the quarter
was a
loss of 13 cents​.
    * The company reported a quarterly loss of $11.51 million.
    * Aquestive Therapeutics Inc shares had risen by 3.4% this
quarter and gained 155.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Aquestive
Therapeutics Inc is $9.50 
This summary was machine generated from LSEG data November 5 at
07:54 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.13          -0.13          Met
 Jun. 30 2024      -0.12          -0.03          Beat
 Mar. 31 2024      -0.08          -0.17          Missed
 Dec. 31 2023      -0.08          -0.11          Missed